China FDA loosens documentation requirements for renewals, clinical trial applications

By Stewart Eisenhart, Emergo Group

Chinese medical device market regulators have amended requirements for documentation related to registration renewals as well as clinical trial applications to simplify compliance.

Get the full story here at the Emergo Group’s blog.

The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees.

The post China FDA loosens documentation requirements for renewals, clinical trial applications appeared first on MassDevice.

from MassDevice https://ift.tt/2NVeLBO